Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND) [Phase 2]
Phase 2 clinical trial sponsored by the University of Virginia evaluating SHUTi MIND, an Internet-based program to address insomnia and asso…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Study Watch Sleep Metric Performance Characterization Study
Completed study characterizing the sleep metric performance of a wearable watch in sleep-related conditions.
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Written Exposure Therapy and App-Delivered Mindfulness Meditation for PTSD in China: A Pilot Study [NA]
A pilot clinical trial in China evaluating Written Exposure Therapy and app-delivered mindfulness meditation for post-traumatic stress disor…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Digital Behavioral Therapy for Sleep Problems [NA]
Clinical trial evaluating digital behavioral therapy for insomnia conducted by UCLA has been terminated.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Osteopathic Protocol for Insomnia in College Students [NA]
A registered clinical trial evaluating an osteopathic protocol for insomnia in college students; the study status is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Heart Failure Insomnia Treatment Study [NA]
A completed clinical trial update from Ohio State University evaluating insomnia treatment in patients with heart failure; the status is com…
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Enhanced CBTi for Older Adult Sleep and Cognition [Phase 2, Phase 3]
Phase 2/3 trial update on enhanced CBT-i for insomnia in older adults with cognitive impairment (Alzheimer's disease-related dementias).
-
FDA approval · 2024-04-04FDA Approved: ULTRA SLEEP AID — Supplemental Application (Walgreen Company)
FDA approved a supplemental application for Ultra Sleep Aid (doxylamine succinate) from Walgreens Company, updating its labeling for use as …
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Prescription Digital Therapeutic for the Treatment of Insomnia [NA]
Completed clinical trial of a prescription digital therapeutic for insomnia with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Safety and Efficacy of Chronic Hypnotic Use 2 [Phase 4]
Phase 4 trial update assessing safety and efficacy of chronic hypnotic use for chronic insomnia; results posted after completion.
-
FDA approval · 2024-03-20FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved a generic diphenhydramine hydrochloride product through an Original Application (ANDA 218448) by Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISA [Phase 4]
A Phase 4 clinical trial evaluating eszopiclone's impact on adherence to CPAP therapy and insomnia severity in patients with comorbid insomn…
-
FDA approval · 2024-03-14FDA Approved: TEMAZEPAM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Temazepam (generic) from Ascend Laboratories, LLC.
-
FDA approval · 2024-02-20FDA Approved: ULTRA SLEEP AID — Supplemental Application (Walgreen Company)
FDA approved Walgreens' supplemental application for Ultra Sleep Aid (doxylamine succinate) under the ANDA framework, indicating a supplemen…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: The Efficacy of Suvorexant in Treatment of Patients With Substance Use Disorder and Insomnia: A Pilot Open Trial [Phase 2, Phase 3]
Pilot open-label trial examining suvorexant for sleep disturbance and craving in substance use disorder shows completed study with posted re…
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis [Phase 3]
A Phase 3 trial evaluated short- and long-term effectiveness of existing insomnia therapies in patients undergoing hemodialysis (end-stage r…
-
FDA approval · 2024-01-16FDA Approved: DOXEPIN — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for the generic doxepin from Actavis Pharma, Inc., adding regulatory authorization for this prod…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia [Phase 4]
Phase 4 trial evaluating suvorexant for efficacy in patients with effectively treated restless legs syndrome and persistent chronic insomnia…
-
FDA approval · 2024-01-04FDA Approved: ESZOPICLONE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approves Camber Pharmaceuticals' original ANDA for eszopiclone, a generic sleep medication used to treat insomnia.
-
FDA label_change · 2023-12-27FDA Approved: PROMETHAZINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Promethazine hydrochloride from Hikma Pharmaceuticals USA, authorizing changes to the product la…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Brief Behavioral Treatment for Insomnia in Cancer Survivors [NA]
A completed clinical trial evaluated Brief Behavioral Treatment for Insomnia in cancer survivors. Results from the trial have been posted (2…
-
FDA approval · 2023-11-18FDA Approved: TEMAZEPAM — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for temazepam submitted by Actavis Pharma, Inc., under the ANDA process.
-
FDA approval · 2023-11-17FDA Approved: TEMAZEPAM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Temazepam from Amneal Pharmaceuticals LLC under the ANDA program.
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Effect of Medical Marijuana on Neurocognition and Escalation of Use [NA]
Clinical trial update on the effects of medical marijuana on neurocognition and escalation of use; study completed with results posted in 20…
-
FDA approval · 2023-10-30FDA Approved: QUVIVIQ — Supplemental Application (Idorsia Pharmaceuticals Ltd)
FDA approved a supplemental application for QUVIVIQ (daridorexant) from Idorsia Pharmaceuticals Ltd, updating the product's labeling.